Delivra Health Brands Inc. (TSE:DHB) has released an update.
Delivra Health Brands Inc. has reported a robust second quarter for fiscal 2024 with a 39% increase in year-over-year net revenue and positive EBITDA, despite a slight net revenue dip due to lower U.S. sales of Dream Water. The company’s gross profit margin improved to 54%, up from 41% the previous year, attributed to a higher percentage of profitable customers. Delivra Health continues to expand its market presence with increased marketing efforts and new product initiatives.
For further insights into TSE:DHB stock, check out TipRanks’ Stock Analysis page.
